Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37:2768–82. https://doi.org/10.1016/j.vaccine.2019.04.020.

Article  PubMed  Google Scholar 

Mallory ML, Lindesmith LC, Baric RS. Vaccination-induced herd immunity: successes and challenges. J Allergy Clin Immunol. 2018;142:64–6. https://doi.org/10.1016/j.jaci.2018.05.007.

Article  PubMed  PubMed Central  Google Scholar 

Taha S, Taha MK, Deghmane AE. Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France. NPJ Vaccines. 2022;7:73. https://doi.org/10.1038/s41541-022-00488-8.

Article  PubMed  PubMed Central  Google Scholar 

Carr JP, MacLennan JM, Plested E, et al. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Clin Microbiol Infect. 2022;28:1649.e1–e8. https://doi.org/10.1016/j.cmi.2022.07.004.

Article  Google Scholar 

Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020;8:1521. https://doi.org/10.3390/microorganisms8101521.

Article  PubMed  PubMed Central  Google Scholar 

Martinón-Torres F, Taha MK, Knuf M, et al. Evolving strategies for meningococcal vaccination in Europe: overview and key determinants for current and future considerations. Pathog Glob Health. 2022;116:85–98. https://doi.org/10.1080/20477724.2021.1972663.

Article  PubMed  Google Scholar 

Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69:1–41. https://doi.org/10.15585/mmwr.rr6909a1.

Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30:B3–9. https://doi.org/10.1016/j.vaccine.2011.12.062.

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention. Chapter 14: Meningococcal Disease. In: Hall E, Wodi AP, Hamborsky J, et al, editors. The Pink Book: Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C.: Public Health Foundation; 2021.

Bosis S, Mayer A, Esposito S. Meningococcal disease in childhood: epidemiology, clinical features and prevention. J Prev Med Hyg. 2015;56:E121–4.

PubMed  PubMed Central  Google Scholar 

Martinón-Torres F, Salas A, Rivero-Calle I, et al. Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study. Lancet Child Adolesc Health. 2018;2:404–14. https://doi.org/10.1016/s2352-4642(18)30113-5.

Article  PubMed  Google Scholar 

Miller L, Arakaki L, Ramautar A, et al. Elevated risk for invasive meningococcal disease among persons with HIV. Ann Intern Med. 2014;160:30–7. https://doi.org/10.7326/0003-4819-160-1-201401070-00731.

Article  PubMed  Google Scholar 

Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1–28.

PubMed  Google Scholar 

Applegate AO, Fong VC, Tardivel K, Lippold SA, Zarate S. Notes from the field: meningococcal disease in an international traveler on eculizumab therapy — United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:696–7. https://doi.org/10.15585/mmwr.mm6527a3.

Sejvar JJ, Johnson D, Popovic T, et al. Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol. 2005;43:4811–4. https://doi.org/10.1128/jcm.43.9.4811-4814.2005.

Article  PubMed  PubMed Central  Google Scholar 

Martinelli D, Fortunato F, Prato R. Estimates of the burden of meningococcal disease in Italy: implications for prevention and control. J Prev Med Hyg. 2015;56:E112–5.

PubMed  PubMed Central  Google Scholar 

Corr M, Waterfield T, Shields M. Fifteen-minute consultation: symptoms and signs of meningococcal disease. Arch Dis Child Educ Pract Ed. 2020;105:200–3. https://doi.org/10.1136/archdischild-2019-317722.

Article  PubMed  Google Scholar 

Torres-Duque CA, Patino CM, Ferreira JC. Case series: an essential study design to build knowledge and pose hypotheses for rare and new diseases. J Bras Pneumol. 2020;46:e20200389. https://doi.org/10.36416/1806-3756/e20200389.

Sudbury EL, O’Sullivan S, Lister D, Varghese D, Satharasinghe K. Case manifestations and public health response for outbreak of meningococcal W disease, Central Australia, 2017. Emerg Infect Dis. 2020;26:1355–63. https://doi.org/10.3201/eid2607.181941.

Article  PubMed  PubMed Central  Google Scholar 

O’Connor L, Ward M, Bennett D, et al. A prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013. Euro Surveill. 2015;20:21139. https://doi.org/10.2807/1560-7917.es2015.20.21.21139.

Article  PubMed  Google Scholar 

Anderson AJ, Bowen AC, Hazelton B, O’Brien M, Blyth CC, Campbell AJ. Meningococcal serotype W septic arthritis: case series in children. J Paediatr Child Health. 2021;57:1990–4. https://doi.org/10.1111/jpc.15385.

Article  PubMed  Google Scholar 

Boyle C, Howard T, Griffith D, Cowie J. Primary meningococcal septic arthritis with multiple native joint involvement. BMJ Case Rep. 2018;2018:bcr2017223197. https://doi.org/10.1136/bcr-2017-223197.

Campbell H, Parikh SR, Borrow R, Kaczmarski E, Ramsay ME, Ladhani SN. Presentation with gastrointestinal symptoms and high case fatality associated with group W meningococcal disease (MenW) in teenagers, England, July 2015 to January 2016. Euro Surveill. 2016;21:pii=30175. https://doi.org/10.2807/1560-7917.Es.2016.21.12.30175.

Dapueto G, Barrios P, Zabala C, Peluffo G, Giachetto G. Primary meningococcal arthritis of the hip due to serogroup W in a pediatric patient. Bol Med Hosp Infant Mex. 2021;78:631–5. https://doi.org/10.24875/bmhim.20000375.

Fidder AR, de Hartog B, Faber T. Child with serogroup W135 primary meningococcal septic arthritis. BMJ Case Rep. 2019;12:e229510. https://doi.org/10.1136/bcr-2019-229510.

Article  PubMed  PubMed Central  Google Scholar 

Ricci S, Montemaggi A, Nieddu F, et al. Is primary meningococcal arthritis in children more frequent than we expect? Two pediatric case reports revealed by molecular test. BMC Infect Dis. 2018;18:703. https://doi.org/10.1186/s12879-018-3602-y.

Article  PubMed  PubMed Central  Google Scholar 

O’Rourke C, Garden M, Joyce P, Pagliaro T, Gray H, Wilks K. Serogroup Y primary meningococcal arthritis in a child. J Paediatr Child Health. 2018;54:689–91. https://doi.org/10.1111/jpc.13844.

Article  PubMed  Google Scholar 

Soler-Garcia A, Fernández de Sevilla M, Abad R, et al. Meningococcal serogroup B disease in vaccinated children. J Pediatr Infect Dis Soc. 2020;9:454–9. https://doi.org/10.1093/jpids/piz071.

Hu S, Zhang W, Li F, et al. Neisseria meningitidis serogroup W135 sequence type 11, Anhui Province, China, 2011–2013. Emerg Infect Dis. 2014;20:1236–8. https://doi.org/10.3201/eid2007.131138.

Article  PubMed  PubMed Central  Google Scholar 

Li B, Zhang L, Liu M, et al. The molecular characteristics of Neisseria meningitidis serogroup Y clonal complex 23 first emerge in China. J Infect. 2019;79:612–25. https://doi.org/10.1016/j.jinf.2019.07.001.

Article  PubMed  Google Scholar 

Basani L, Aepala R. Neisseria meningitidis causing multiple cerebral abscesses in early neonatal period: case report and review of literature. J Clin Diagn Res. 2017;11:SD01–3. https://doi.org/10.7860/jcdr/2017/25284.10151.

Kawasaki Y, Matsubara K, Takahashi H, et al. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: the first case in Japan. J Infect Chemother. 2018;24:305–8. https://doi.org/10.1016/j.jiac.2017.11.001.

Article  PubMed  Google Scholar 

Akcay N, Kihtir HS, Ozcelik G, Barlas UK, Petmezci MT, Sevketoglu E. Immunoadsorption therapy for a meningococcemia patient with myocarditis, adrenal hemorrhage, and purpura fulminans: a case report. Braz J Anesthesiol. 2022;72:819–22. https://doi.org/10.1016/j.bjane.2021.06.021.

Article  PubMed  Google Scholar 

Nguyen N, Ashong D. Neisseria Meningitidis. Treasure Island: StatPearls; 2022.

Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccine Immunother. 2019;15:459–69. https://doi.org/10.1080/21645515.2018.1528831.

Article  Google Scholar 

Di Pietro GM, Biffi G, Castellazzi ML, et al. Meningococcal disease in pediatric age: a focus on epidemiology and prevention. Int J Environ Res Public Health. 2022;19:4035. https://doi.org/10.3390/ijerph19074035.

Article  PubMed  PubMed Central  Google Scholar 

Tully J, Viner RM, Coen PG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006;332:445–50. https://doi.org/10.1136/bmj.38725.728472.BE.

Article  PubMed  PubMed Central  Google Scholar 

Thangarajah D, Guglielmino CJD, Lambert SB, et al. Genomic characterization of recent and historic meningococcal serogroup E invasive disease in Australia: a case series. Clin Infect Dis. 2020;70:1761–3. https://doi.org/10.1093/cid/ciz767.

Article  PubMed  Google Scholar 

Marshall GS, Fergie J, Presa J, Peyrani P. Rationale for the development of a pentavalent meningococcal vaccine: a US-focused review. Infect Dis Ther. 2022;11:937–51. https://doi.org/10.1007/s40121-022-00609-9.

Article  PubMed  PubMed Central  Google Scholar 

Chen WH, Neuzil KM, Boyce CR, et al. Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. Lancet Infect Dis. 2018;18:1088–96. https://doi.org/10.1016/s1473-3099(18)30400-6.

Article  PubMed  Google Scholar 

ClinicalTrials.gov. Identifier NCT04502693. Effectiveness of GlaxoSmithKline Biologicals S.A's meningococcal group B and combined ABCWY vaccines in healthy adolescents and young adults. https://clinicaltrials.gov/ct2/show/NCT04502693?term=205416&draw=2&rank=1. Accessed 21 Mar 2023.

Vienne P, Ducos-Galand M, Guiyoule A, et al. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37:1639–42. https://doi.org/10.1086/379719.

Article  PubMed  Google Scholar 

Kallinich T, von Bernuth H, Kuhns M, Elias J, Bertelmann E, Pleyer U. Fulminant endophthalmitis in a child caused by Neisseria meningitidis serogroup C detected by specific DNA. J Pediatric Infect Dis Soc. 2016;5:e13–6. https://doi.org/10.1093/jpids/piw012.

Article  PubMed  Google Scholar 

Wang B, Giles L, Andraweera P, et al. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. Lancet Infect Dis. 2022;22:1011–20. https://doi.org/10.1016/s1473-3099(21)00754-4.

Article